These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diversity and Function of Maternal HIV-1-Specific Antibodies at the Time of Vertical Transmission. Doepker LE; Simonich CA; Ralph D; Shipley MM; Garrett M; Gobillot T; Vigdorovich V; Sather DN; Nduati R; Matsen FA; Overbaugh JM J Virol; 2020 Apr; 94(9):. PubMed ID: 32075936 [TBL] [Abstract][Full Text] [Related]
7. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR J Virol; 2017 May; 91(9):. PubMed ID: 28202762 [TBL] [Abstract][Full Text] [Related]
8. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals. Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336 [TBL] [Abstract][Full Text] [Related]
9. Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission. Zhang H; Rola M; West JT; Tully DC; Kubis P; He J; Kankasa C; Wood C Virology; 2010 May; 400(2):164-74. PubMed ID: 20096914 [TBL] [Abstract][Full Text] [Related]
10. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. Kumar A; Smith CEP; Giorgi EE; Eudailey J; Martinez DR; Yusim K; Douglas AO; Stamper L; McGuire E; LaBranche CC; Montefiori DC; Fouda GG; Gao F; Permar SR PLoS Pathog; 2018 Apr; 14(4):e1006944. PubMed ID: 29672607 [TBL] [Abstract][Full Text] [Related]
11. The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population. Russell ES; Kwiek JJ; Keys J; Barton K; Mwapasa V; Montefiori DC; Meshnick SR; Swanstrom R J Virol; 2011 Aug; 85(16):8253-62. PubMed ID: 21593171 [TBL] [Abstract][Full Text] [Related]
12. Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants. Martinez DR; Tu JJ; Kumar A; Mangold JF; Mangan RJ; Goswami R; Giorgi EE; Chen J; Mengual M; Douglas AO; Heimsath H; Saunders KO; Nicely NI; Eudailey J; Hernandez G; Morgan-Asiedu PK; Wiehe K; Haynes BF; Moody MA; LaBranche C; Montefiori DC; Gao F; Permar SR mBio; 2020 Mar; 11(2):. PubMed ID: 32156815 [TBL] [Abstract][Full Text] [Related]
13. Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials. Hompe ED; Mangold JF; Kumar A; Eudailey JA; McGuire E; Haynes BF; Moody MA; Wright PF; Fouda GG; Giorgi EE; Gao F; Permar SR mSphere; 2020 Jun; 5(3):. PubMed ID: 32493720 [TBL] [Abstract][Full Text] [Related]
14. Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants. Fouda GG; Mahlokozera T; Salazar-Gonzalez JF; Salazar MG; Learn G; Kumar SB; Dennison SM; Russell E; Rizzolo K; Jaeger F; Cai F; Vandergrift NA; Gao F; Hahn B; Shaw GM; Ochsenbauer C; Swanstrom R; Meshnick S; Mwapasa V; Kalilani L; Fiscus S; Montefiori D; Haynes B; Kwiek J; Alam SM; Permar SR Retrovirology; 2013 Jan; 10():3. PubMed ID: 23305422 [TBL] [Abstract][Full Text] [Related]
16. Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1. Naiman NE; Slyker J; Nduati R; Overbaugh JM J Infect Dis; 2020 Jan; 221(2):232-237. PubMed ID: 31504656 [TBL] [Abstract][Full Text] [Related]
17. Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers. Kumar A; Giorgi EE; Tu JJ; Martinez DR; Eudailey J; Mengual M; Honnayakanahalli Marichannegowda M; Van Dyke R; Gao F; Permar SR PLoS Pathog; 2021 Apr; 17(4):e1009478. PubMed ID: 33798244 [TBL] [Abstract][Full Text] [Related]
18. Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand. Louisirirotchanakul S; Beddows S; Cheingsong R; Shaffer N; Mastro TD; Likanonsakul S; Wasi C; Taylor GP; Weber JN J Acquir Immune Defic Syndr; 1999 Aug; 21(4):259-65. PubMed ID: 10428102 [TBL] [Abstract][Full Text] [Related]
19. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection. Lynch JB; Nduati R; Blish CA; Richardson BA; Mabuka JM; Jalalian-Lechak Z; John-Stewart G; Overbaugh J J Virol; 2011 Jun; 85(11):5252-61. PubMed ID: 21411521 [TBL] [Abstract][Full Text] [Related]
20. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection. Diomede L; Nyoka S; Pastori C; Scotti L; Zambon A; Sherman G; Gray CM; Sarzotti-Kelsoe M; Lopalco L J Virol; 2012 Apr; 86(8):4129-38. PubMed ID: 22301151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]